Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients withde novoacute myeloid leukaemia: a report from the Children's Oncology Group-Reference-Cited by-同舟云学术

Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients withde novoacute myeloid leukaemia: a report from the Children's Oncology Group

Published:2013-05-20 Issue:2 Volume:162 Page:250-262
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Lacayo Norman J.¹²,Alonzo Todd A.¹³,Gayko Urte⁴,Rosen David B.⁴,Westfall Matt⁴,Purvis Norman⁴,Putta Santosh⁴,Louie Brent⁴,Hackett James⁴,Cohen Aileen Cleary⁴,Cesano Alessandra⁴,Gerbing Robert¹,Ravindranath Yaddanapudi¹⁵,Dahl Gary V.¹²,Gamis Alan¹⁶,Meshinchi Soheil¹⁷

Affiliation:

1. Children's Oncology Group; Arcadia CA USA

2. Stanford University School of Medicine and Stanford Cancer Institute; Palo Alto CA USA

3. University of Southern California; Los Angeles CA USA

4. Nodality Inc.; South San Francisco CA USA

5. Wayne State University; Detroit MI USA

6. Children's Mercy Hospitals & Clinics; Kansas City MO USA

7. Fred Hutchinson Comprehensive Cancer Research Center; Seattle WA USA

Funder

Children's Oncology Group (COG)

Valvano Foundation

Publisher